Talk:Mesembrine
 | This article is rated Start-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||
| |||||||||||
 | The contents of the Total synthesis of mesembrine page were merged into Mesembrine on 17 April 2015. For the contribution history and old versions of the redirected page, please see its history; for the discussion at that location, see its talk page. |
Broken link (link 3) in main page. —Preceding unsigned comment added by 71.98.71.8 (talk) 00:05, 26 November 2007 (UTC)
There needs to be a PROPER reference for mesembrine being an SSRI (or "serotonin uptake inhibitor" as they call it here) - the patent application doesn't count as it doesn't say anything about the validity of the science (as, for example, patents have been granted for perpetual motion machines). 91.106.228.78 (talk) 19:56, 31 January 2009 (UTC)
- I added that reference, and I agree. It's quite annoying because in the "psychedelic culture" it has almost been accepted as truth, and alot of companies are exploiting the results of that patent to promote kanna as a natural SSRI. --Mark PEA (talk) 16:54, 3 February 2009 (UTC)
Contributions by a group of paid PhD students, alarming number of Elsevier citations[edit]
I find alarming that virtually all references are from Elsevier journals (4x Journal of Ethnopharmacology, 1x Food and Chemical Toxicology, 2x Tetrahedron Letters), given that the creator(s) of the main part of this article has been blocked for not disclosing they were paid for creating it for an economic experiment and the resulting article states that they looked at Elsevier articles exclusively. I would like to have a statement of the supervisors, and I think the ethics committees of their institutions should be contacted. Antimanipulator (talk) 20:04, 28 September 2017 (UTC)